Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort

NCT07454486 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT07454486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07454486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort
Lead sponsor
Aarhus University Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
March 15, 2026
Completion date
December 30, 2031
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer (btc), biliary tract cancer (cca), biliary tract cancers (btc), cholangiocarcinoma, cholangiocarcinoma metastatic, cholangiocarcinoma non-resectable, cholangiocarcinoma of the bile duct, cholangiocarcinoma resectable, cholangiocarcinoma, extrahepatic, cholangiocarcinoma, hilar, cholangiocarcinoma, intrahepatic, cholangiocarcinoma, perihilar, cholangiocarcinoma; liver, gall bladder cancer